Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2
- 289 Downloads
The conserved M2 protein of influenza A virus is considered as a promising candidate target for a broad-spectrum, recombinant influenza A vaccine. In the present study, the open reading frame (ORF) of avian influenza A/chicken/Iran/101/1998 (H9N2) M2 gene was amplified then cloned in pAED4, prokaryotic expression vector. M2 protein was produced through the expression of this recombinant expression vector (pAED4-M2) in E. coli BL21 (DE3) strain. The expressed M2 protein was analyzed on SDS-PAGE. Western blot assay was used to examine the immunoreaction of the expressed protein using commercial polyclonal anti-M2 antibody. The antigenicity and biological activity of the recombinant protein was also qualitatively detected on infected MDCK cells surface by immunofluorescence assay using rabbit’s immunized antiserum. So, according to the sequence alignment based on the mentioned isolate and the result of immunoassay reaction, it seems recombinant vaccine based on A/chicken/Iran/101/1998(H9N2) M2 protein isolate might cover majority of influenza A virus strains specially H5 and H9 circulating in Iran and neighbor regions significantly.
KeywordsM2 protein pAED4 SDS-PAGE Expression Avian influenza
This project was financially supported by a grant of the Razi Vaccine and Serum Research Institute (RVSRI). The authors wish to thank Dr. Paykari, Dr. Lotfi, Dr. Khaki, Dr. Mirafzali, and Dr. Momays faculty members of Razi Vaccine and Serum Research Institute for their helpful contribution to this project.
- 1.Epstein SL, Stack A, Misplon JA, Lo CY, Mostowski H, Bennink J, Subbarao K (2000) Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge. Int Immunol 12:91–101CrossRefPubMedGoogle Scholar
- 5.Ebrahimi SM, Aghaiypour K, Nili H (2008) Sequence analysis of M2 gene of avian influenza virus strain (A/chicken/Iran/101/98 (H9N2)) as an oil vaccine seed. Iran J Biotechnol 6(4):235–238Google Scholar
- 6.Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA (2004) Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22:2993–3003CrossRefPubMedGoogle Scholar
- 10.Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos JL, Gerhard W (2003) Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21:2616–2626CrossRefPubMedGoogle Scholar
- 15.Johansson BE, Moran TM, Bona CA, Popple SW, Kilbourne ED (1987) Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J Immunol 139(6):2010–2014PubMedGoogle Scholar
- 17.Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos LJ, Gerhard W (2003) Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21(19–20):2616–2626CrossRefPubMedGoogle Scholar
- 18.Andrea J, Nicole S, Tazio S, Martin FB (2004) Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172:5598–5605Google Scholar